(+)-JQ-1 AS A BET INHIBITOR SECRETS

For drug discovery aimed at creating next- or 3rd-generation therapeutics, a single could reasonably argue that TID/MoA needs to be acquired early in the process so as to add value, as present treatments can be obtained to Those people in need (Determine 1). For others, Particularly the neurological and psychiatric diseases for which TID/MoA is far